Group One Trading
SMMT icon

Group One Trading’s Summit Therapeutics SMMT Stock Holding History

Group One Trading’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.18M Sell
220,400
-5,900
-3% -$95.4K 0.01% 1442
2025
Q4 		$3.96M Sell
226,300
-205,100
-48% -$3.86M 0.01% 1709
2025
Q3 		$8.91M Sell
431,400
-108,800
-20% -$2.64M 0.02% 991
2025
Q2 		$11.5M Buy
540,200
+280,000
+108% +$6.39M 0.03% 723
2025
Q1 		$5.02M Buy
260,200
+36,300
+16% +$728K 0.01% 1070
2024
Q4 		$4M Sell
223,900
-188,800
-46% -$3.66M 0.01% 1323
2024
Q3 		$9.04M Sell
412,700
-135,500
-25% -$1.89M 0.03% 664
2024
Q2 		$4.28M Buy
548,200
+467,300
+578% +$2.52M 0.02% 904
2024
Q1 		$335K Sell
80,900
-157,900
-66% -$628K ﹤0.01% 3116
2023
Q4 		$623K Sell
238,800
-234,800
-50% -$483K ﹤0.01% 2882
2023
Q3 		$886K Buy
473,600
+436,000
+1,160% +$831K ﹤0.01% 2390
2023
Q2 		$94.4K Sell
37,600
-424,200
-92% -$774K ﹤0.01% 4683
2023
Q1 		$808K Buy
461,800
+205,200
+80% +$560K ﹤0.01% 2315
2022
Q4 		$1.09M Buy
256,600
+224,900
+709% +$409K ﹤0.01% 2334
2022
Q3 		$38K Buy
31,700
+30,300
+2,164% +$34.3K ﹤0.01% 5619
2022
Q2 		$1K Buy
1,400
+1,100
+367% +$1.54K ﹤0.01% 7620
2022
Q1 		$1K Sell
300
-12,100
-98% -$30.5K ﹤0.01% 7872
2021
Q4 		$33K Sell
12,400
-23,800
-66% -$114K ﹤0.01% 6646
2021
Q3 		$181K Buy
36,200
+17,600
+95% +$126K ﹤0.01% 5279
2021
Q2 		$139K Buy
18,600
+17,700
+1,967% +$116K ﹤0.01% 5618
2021
Q1 		$5K Buy
+900
New +$5.81K ﹤0.01% 7246

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Group One Trading's SMMT Position: Q1 2026 in Review

Group One Trading increased its Summit Therapeutics (SMMT) stake by 36% in Q1 2026, buying an estimated $184K and bringing the position to 42,781 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Group One Trading first reported a position in SMMT in Q4 2018 and has held it in 19 quarters since. The position peaked at $4.09M in Q3 2024. 222 funds tracked by Wall St. Rank hold SMMT as of Q1 2026.

  • Group One Trading held 42,781 shares of Summit Therapeutics worth $811K as of Q1 2026.
  • Group One Trading bought 11,371 Summit Therapeutics shares in Q1 2026, an estimated $184K.
  • Summit Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2907 holding.
  • Group One Trading first reported a position in Summit Therapeutics in Q4 2018 and has held it in 19 quarters since.
  • Group One Trading's Summit Therapeutics position peaked at $4.09M in Q3 2024.
  • 222 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.